List of insiders holdings for PHASEBIO PHARMACEUTICALS INC C:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Thorp Clay Director | 2023-05-19 16:18:34 | 36,693 3,545,040 | 3,581,733 | Form 4 |
| ASTRAZENECA PLC Zeneca Inc. 10% Owner | 2018-10-29 13:03:38 | 3,004,554 0 | 3,004,554 | Form 13D |
| Hatteras Venture Advisors III LLC Hatteras Ventures Partners III LP Hatteras Venture Affiliates III Lp Hatteras Venture Partners I LP Catalysta Ventures LLC Venture Capital Multiplier Fund INGRAM ROBERT ALEXANDER LEE KENNETH B JR Reed Douglas MD Crumpler John 10% Owner | 2019-07-29 16:27:08 | 2,489,156 0 | 2,489,156 | Form 13D |
| Mow Jonathan P Chief Executive Officer | 2022-05-24 17:14:47 | 132,502 51,199 | 183,701 | Form 4 |
| Lee John Sang Chief Medical Officer | 2022-02-28 19:23:31 | 140,250 0 | 140,250 | Form 4 |
| Sharp John P Chief Financial Officer | 2022-05-24 17:12:42 | 65,767 0 | 65,767 | Form 4 |
| Hutson Nancy J Director | 2023-05-19 16:15:57 | 37,510 4,000 | 41,510 | Form 4 |
| Arnold Susan Elizabeth SVP, Technical Operations | 2022-05-24 17:15:27 | 41,236 0 | 41,236 | Form 4 |
| TUFTS LINDA Director | 2019-03-01 17:23:07 | 36,000 0 | 36,000 | Form 4 |
| Birchall Jonathan Chief Commercial Officer | 2022-05-24 17:13:06 | 20,000 0 | 20,000 | Form 4 |
| Klein Peter Justin Director | 2021-06-04 18:07:58 | 14,000 0 | 14,000 | Form 4 |
| Mukhopadhyay Bibhash Director | 2019-05-13 16:44:48 | 11,000 0 | 11,000 | Form 4 |
| HARRIGAN EDMUND Director | 2023-05-19 16:17:34 | 9,750 0 | 9,750 | Form 4 |
| Ballance David James VP, Research and Sci. Affairs | 2020-11-23 18:38:37 | 8,519 0 | 8,519 | Form 4 |
| Hanson Kristopher SVP and General Counsel | 2022-05-24 17:13:29 | 8,463 0 | 8,463 | Form 4 |
| York Michael VP, Corporate Development | 2021-05-24 18:10:24 | 7,059 0 | 7,059 | Form 4 |
| Loewy Caroline M Director | 2023-05-19 16:16:48 | 3,750 0 | 3,750 | Form 4 |
| Sapir Alex Director | 2023-05-19 16:17:17 | 3,750 0 | 3,750 | Form 4 |
| Humphries William D. Director | 2023-05-19 16:18:07 | 2,538 0 | 2,538 | Form 4 |
| Burkhardt Glen SVP of Human Resources | 2022-05-24 17:14:08 | 0 0 | 0 | Form 4 |
| NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd SANDELL SCOTT D KERINS PATRICK J BASKETT FOREST 10% Owner | 2022-11-04 16:42:40 | 0 0 | 0 | Form 13D |
| Rivers Tyrell Director | 2018-10-17 20:04:05 | 0 0 | 0 | Form 3 |
| NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd BARRETT M JAMES BARRIS PETER J BASKETT FOREST KERINS PATRICK J MOTT DAVID M SANDELL SCOTT D Viswanathan Ravi 10% Owner | 2022-11-04 16:42:40 | 0 0 | 0 | Form 13D |
| van den Broek Richard Director | 2023-05-19 16:18:54 | 0 0 | 0 | Form 4 |